Professor Otavio Berwanger

Professor Berwanger leads the Institute’s work in the UK in partnership with Imperial College London, with a core focus on health systems science, multimorbidity, women’s health, large-scale clinical trials and planetary health. He is also building on his personal research interests in exploring innovative clinical trial models, as well as the conduct of efficient implementation science studies.

Prior to joining The George Institute, he was Director of the Academic Research Organisation (ARO) of the Albert Einstein Israelite Hospital in São Paulo, Brazil. An esteemed cardiologist and clinical trialist, Professor Berwanger has extensive research and managerial experience and has led large-scale, randomised clinical trials nationally and internationally across many countries including Brazil, Australia, New Zealand, Canada, China, Chile, Argentina, Peru and Colombia. Trials led by him have been published in high-impact journals such as the New England Journal of Medicine, The Lancet, JAMA and the BMJ.